LEADER 02842nam  22006013u 450 
001 9910558694403321
005 20240315204743.0
010   $a3-030-94577-4
035   $a(CKB)5590000000901948
035   $aEBL6947060
035   $a(AU-PeEL)EBL6947060
035   $a(MiAaPQ)EBC6947060
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/81294
035   $a(PPN)262173123
035   $a(EXLCZ)995590000000901948
100   $a20220617d2022||||  u||         |
101 0 $aeng
135   $aur|n|---|||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aAssessment of cancer screening $ea primer /$fPamela M. Marcus
210   $aCham$cSpringer Nature$d2022
210  1$aCham :$cSpringer International Publishing AG,$d2022.
210  4$d©2022
215   $a1 online resource (138 p.)
300   $aDescription based upon print version of record.
311   $a3-030-94576-6 
320   $aIncludes bibliographical references.
330   $aCancer screening is a prominent strategy in cancer control in the United States, yet the ability to correctly interpret cancer screening data eludes many researchers, clinicians, and policy makers. This open access primer rectifies that situation by teaching readers, in simple language and with straightforward examples, why and how the population-level cancer burden changes when screening is implemented, and how we assess whether that change is of benefit. This book provides an in-depth look at the many aspects of cancer screening and its assessment, including screening phenomena, performance measures, population-level outcomes, research designs, and other important and timely topics. Concise, accessible, and focused, Assessment of Cancer Screening: A Primer is best suited to those with education or experience in clinical research or public health in the United States - no previous knowledge of cancer screening assessment is necessary. This is the first text dedicated to cancer screening theory and methodology to be published in 20 years.
606   $aEarly Detection of Cancer
606   $aCàncer$2thub
606   $aDiagnòstic$2thub
606   $aCribratge$2thub
608   $aLlibres electrònics$2thub
610   $aCancer Prevention
610   $aCancer Statistics
610   $aCancer Performance Measures
610   $aCancer Population Measures
610   $aCancer Screening Process
610   $aOpen Access
615  2$aEarly Detection of Cancer.
615  7$aCàncer
615  7$aDiagnòstic
615  7$aCribratge
700   $aMarcus$b Pamela M$01235150
801  0$bAU-PeEL
801  1$bAU-PeEL
801  2$bAU-PeEL
906   $aBOOK
912   $a9910558694403321
996   $aAssessment of Cancer Screening$92869018
997   $aUNINA